WEBULL
News
OSRHW
0.0596
-0.33%
-0.0002
Emerging Growth Research Reaffirms Buy on OSR Holdings With $10 Price Target
Reuters · 3d ago
BRIEF-OSR Holdings Says Vaximm AG Shortens Exclusivity Period With BCM Europe To Three Months
Reuters · 5d ago
OSR HOLDINGS INC - VAXIMM AG SHORTENS EXCLUSIVITY PERIOD WITH BCM EUROPE TO THREE MONTHS
Reuters · 5d ago
Vaximm AG Shortens Exclusivity Period With BCM Europe for Cancer Immunotherapy Deal
Reuters · 5d ago
OSR Holdings to Present Corporate Overview at Emerging Growth Conference
Reuters · 6d ago
Vaximm AG Enters $835M License Term Sheet With BCM Europe for Cancer Immunotherapy
Reuters · 11/25 15:56
OSR Holdings Reports High Accuracy for Woori IO Noninvasive Glucose Monitor in Pilot Study
Reuters · 11/25 06:43
Vaximm AG Enters $20M Term Sheet for VXM01 License Negotiations
Reuters · 11/21 14:20
Vaximm AG Names Scientific Co-Founder Andreas Niethammer as CEO
Reuters · 11/14 16:11
OSR HOLDINGS APPOINTS SCIENTIFIC CO-FOUNDER DR. ANDREAS NIETHAMMER AS CHIEF EXECUTIVE OFFICER OF VAXIMM AG TO LEAD NEXT PHASE OF IMMUNO-ONCOLOGY EXPANSION
Reuters · 11/14 16:11
OSR Holdings Reports High Accuracy in Woori IO Noninvasive Glucose Monitor Pilot Study
Reuters · 11/06 13:31
OSR HOLDINGS ANNOUNCES WOORI IO'S NONINVASIVE GLUCOSE MONITOR DEMONSTRATES HIGH ACCURACY AND PRECISION IN COMPANY-SPONSORED PILOT STUDY
Reuters · 11/06 13:30
OSR Holdings Inc. Files Initial Statement of Beneficial Ownership for Director Reto Kaspar Fierz
Reuters · 10/24 16:58
Emerging Growth Research Initiates Buy Rating on OSR Holdings with $10 Price Target
Reuters · 10/20 15:40
OSR Holdings to Acquire Woori IO, Advancing Noninvasive Glucose Monitoring Technology
Reuters · 10/16 15:11
OSR Holdings to Acquire Woori IO, Advancing Noninvasive Glucose Monitoring Technology
Reuters · 10/14 12:31
OSR HOLDINGS INC - WORIO SHAREHOLDERS TO RECEIVE OSRK SHARES WORTH $10.5 MLN
Reuters · 10/14 12:31
OSR Holdings Inc. Held Annual Stockholders Meeting
Reuters · 09/23 15:27
Weekly Report: what happened at OSRHW last week (0908-0912)?
Weekly Report · 09/15 11:11
OSR Holdings Inc. reagiert auf jüngste Kursbewegungen der eigenen Aktie
Reuters · 09/09 21:30
More
Webull provides a variety of real-time OSRHW stock news. You can receive the latest news about OSR Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About OSRHW
Bellevue Life Sciences Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business industry or sector. The Company intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The Company neither engaged in any operations nor generated any revenues.